Sign inGet started

Cunningham, Richard Anthony

Insider CIK 1624783 · NONE President and CEO · TYME Chief Executive Officer, Director · ANEB Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANEB Anebulo Pharmaceuticals, I A Award deriv2025-04-042025-04-07316,352— $0316,352SEC↗
ANEB Anebulo Pharmaceuticals, I A Award deriv2024-12-092024-12-10254,433— $0254,433SEC↗
ANEB Anebulo Pharmaceuticals, I A Award deriv2023-10-062023-10-11600,000— $0600,000SEC↗
TYME TYME TECHNOLOGIES, INC. D To issuer deriv2022-09-162022-09-161,326,000— $00SEC↗
TYME TYME TECHNOLOGIES, INC. D To issuer deriv2022-09-162022-09-16500,000— $00SEC↗
TYME TYME TECHNOLOGIES, INC. D To issuer deriv2022-09-162022-09-162,000,000— $00SEC↗
TYME TYME TECHNOLOGIES, INC. A Award deriv2022-04-252022-04-261,326,000— $01,326,000SEC↗
TYME TYME TECHNOLOGIES, INC. A Award deriv2021-06-142021-06-16500,000— $0500,000SEC↗
TYME TYME TECHNOLOGIES, INC. A Award deriv2020-11-252020-11-302,000,000— $02,000,000SEC↗
NONE Icagen, Inc. A Award deriv2019-04-292019-05-01154,616— $0154,616SEC↗
NONE Icagen, Inc. A Award deriv2018-11-142018-11-16535,000— $0535,000SEC↗
NONE Icagen, Inc. A Award deriv2017-12-292018-01-025,357$0.02 $1075,357SEC↗
NONE Icagen, Inc. P Buy2017-12-292018-01-0221,428$0.37 $7.9K21,428SEC↗
NONE Icagen, Inc. A Award deriv2017-03-152017-03-1620,000— $020,000SEC↗
NONE XRpro Sciences, Inc. A Award deriv2015-01-072015-02-02500,000— $0500,000SEC↗